{"filing":{"accession_number":"0000926617-26-000042","cik":"0000926617","ticker":"AWHL","company_name":"Aspira Women's Health Inc.","form":"8-K","filing_date":"2026-06-09","report_date":null,"primary_document":"awhl-20260529x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000042/awhl-20260529x8k.htm"},"events":[{"id":4294,"run_id":3748,"accession_number":"0000926617-26-000042","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.94,"summary":"Aspira Women's Health entered into a private placement securities purchase agreement on June 5, 2026, issuing 3,300,000 shares of common stock and warrants to purchase 4,455,000 additional shares to accredited and institutional investors for approximately $1.485 million in gross proceeds.","company_name":"Aspira Women's Health Inc.","ticker":"AWHL","filing_date":"2026-06-09","items":[{"id":5410,"accession_number":"0000926617-26-000042","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Aspira Women's Health entered into a private placement securities purchase agreement on June 5, 2026, issuing 3,300,000 shares of common stock and warrants to purchase 4,455,000 additional shares to accredited and institutional investors for approximately $1.485 million in gross proceeds. The issuance of unregistered equity securities with anti-dilutive provisions and registration rights is a classic dilutive issuance event material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T11:49:08.167792+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5411,"accession_number":"0000926617-26-000042","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 explicitly discloses an unregistered sale of equity securities (Common Stock), which is the defining characteristic of a dilutive issuance. The reference to Item 1.01 indicates a material transaction involving the issuance of shares. For a smaller-cap company like Aspira Women's Health, an unregistered equity issuance is typically material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T11:49:08.167792+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5410,"accession_number":"0000926617-26-000042","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Aspira Women's Health entered into a private placement securities purchase agreement on June 5, 2026, issuing 3,300,000 shares of common stock and warrants to purchase 4,455,000 additional shares to accredited and institutional investors for approximately $1.485 million in gross proceeds. The issuance of unregistered equity securities with anti-dilutive provisions and registration rights is a classic dilutive issuance event material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T11:49:08.167792+00:00","company_name":"Aspira Women's Health Inc.","ticker":"AWHL","filing_date":"2026-06-09"},{"id":5411,"accession_number":"0000926617-26-000042","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 explicitly discloses an unregistered sale of equity securities (Common Stock), which is the defining characteristic of a dilutive issuance. The reference to Item 1.01 indicates a material transaction involving the issuance of shares. For a smaller-cap company like Aspira Women's Health, an unregistered equity issuance is typically material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T11:49:08.167792+00:00","company_name":"Aspira Women's Health Inc.","ticker":"AWHL","filing_date":"2026-06-09"}]}